(Q35865198)

10 August 2017

1 reference

title

Review of epidemiological evidence for reproductive and hormonal factors in relation to the risk of epithelial ovarian malignancies (English)

1 reference

10 August 2017

Tomas Riman

1

1 reference

10 August 2017

Staffan Nilsson

series ordinal

2

1 reference

10 August 2017

Ingemar R Persson

series ordinal

3

1 reference

10 August 2017

publication date

1 September 2004

1 reference

Acta Obstetricia et Gynecologica Scandinavica

10 August 2017

published in

1 reference

10 August 2017

volume

83

1 reference

10 August 2017

issue

9

1 reference

10 August 2017

page(s)

783-795

1 reference

Use of proteomic patterns in serum to identify ovarian cancer

10 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.0001-6349.2004.00550.X

Incessant ovulation--a factor in ovarian neoplasia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0001-6349.2004.00550.X

Parity, age at first childbirth, and risk of ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0001-6349.2004.00550.X

Risk factors for ovarian cancer: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0001-6349.2004.00550.X

Pregnancy, breast feeding, and oral contraceptives and the risk of epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0001-6349.2004.00550.X

Oral contraceptives and neoplasia of the ovary

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0001-6349.2004.00550.X

High-dose and low-dose combined oral contraceptives: protection against epithelial ovarian cancer and the length of the protective effect. The WHO Collaborative Study of Neoplasia and Steroid Contraceptives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0001-6349.2004.00550.X

Breast and ovarian cancer incidence after infertility and in vitro fertilisation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0001-6349.2004.00550.X

Hormone replacement therapy formulations and risk of epithelial ovarian carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0001-6349.2004.00550.X

Hormone replacement therapy and risk of epithelial ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0001-6349.2004.00550.X

Estrogen replacement therapy and ovarian cancer mortality in a large prospective study of US women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0001-6349.2004.00550.X

Stilboestrol (diethylstilbestrol) and the risk of ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0001-6349.2004.00550.X

Effects of estrogen plus progestin on gynecologic cancers and associated diagnostic procedures: the Women's Health Initiative randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0001-6349.2004.00550.X

Progestin-induced apoptosis in the Macaque ovarian epithelium: differential regulation of transforming growth factor-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0001-6349.2004.00550.X

Production of steroids by human ovarian surface epithelial cells in culture: possible role of progesterone as growth inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0001-6349.2004.00550.X

Surgical procedures associated with risk of ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0001-6349.2004.00550.X

Histologic transformation of benign endometriosis to early epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0001-6349.2004.00550.X

Hyperestrogenism: a relevant risk factor for the development of cancer from endometriosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0001-6349.2004.00550.X

Prospective study of antibody to human papilloma virus type 16 and risk of cervical, endometrial, and ovarian cancers (United States).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0001-6349.2004.00550.X

Epithelial ovarian cancer risk among women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0001-6349.2004.00550.X

Polycystic ovary syndrome and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0001-6349.2004.00550.X

Over-the-counter analgesics and risk of ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0001-6349.2004.00550.X

Oral contraceptive health benefits: perception versus reality

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0001-6349.2004.00550.X

A Review of Perineal Talc Exposure and Risk of Ovarian Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0001-6349.2004.00550.X

Risk Factors for Epithelial Borderline Ovarian Tumors: Results of a Swedish Case–Control Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0001-6349.2004.00550.X

Risk Factors for Invasive Epithelial Ovarian Cancer: Results from a Swedish Case-Control Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0001-6349.2004.00550.X

Risk of Endometrial Cancer Following Estrogen Replacement With and Without Progestins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0001-6349.2004.00550.X

Infertility, Fertility Drugs, and Ovarian Cancer: A Pooled Analysis of Case-Control Studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0001-6349.2004.00550.X

Infertility, fertility drugs, and invasive ovarian cancer: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0001-6349.2004.00550.X

10.1111/J.0001-6349.2004.00550.X

21 January 2018

Identifiers

DOI

1 reference

10 August 2017

1 reference